Grifols s a

Major-Pharmaceuticals

GRFS


Avinguda de la Generalitat, 152-158
Barcelona , 08174

Executive/
Director

Price

  • Last Close
  • $ 9.11
    $ +0.11 1.22 %
    Aug 29, 2024
  • 52-Week High/Low
  • $11.56 - $5.47
  • YTD
  • -21.2%

  • Trading Volume
  • 139,170
  • Market Cap Full
  • $
  • Shares Outstanding

  • Jan 1, 1970
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 -3.5% -4.5% 17.4% -7.5% 9.5% -5% -5.6% 4% -13.3% -42.2%
Q2 -4.5% 8.8% 12.8% 5.6% 4.2% 4% -0.3% 1.7% 24.3% 1.5%
Q3 -1.9% -4.2% 3.6% -0.1% -3.6% 8% -15.4% -48.2% -0.2% -
Q4 7.9% 2% 6.8% -13.3% 14.3% 8.7% -23.5% 38% 28.3% -
J F M A M J J A S O N D
2024 -30.5% -6.6% -11.1% 1.5% - - - - - - - -
2023 7.2% -4.9% -14.9% 1.2% 10.5% 11.2% 19.1% -13.2% -3.5% -11.5% 19.8% 19.3%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    -4%-2%1%45%-18%26%-20%-39%-24%36%-21%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.50 0.22 0.26 0.29 - 0.24 - - -
Q2 0.43 0.27 0.27 0.31 0.33 - - - 0.09
Q3 0.46 0.28 0.29 - 0.28 - - - -
Q4 - - 0.28 1.03 1.02 1.03 0.33 - -
A 1.4 0.8 1.1 1.6 1.6 1.3 0.3 0 0.09

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Dividend +

Dividend +

2019 2020 2021
Q1 0.14 0.14 0.37
Q2 0.17 - -
Q3 - - -
Q4 - - -
A 0.31 0.14 0.37
Mar
Jun
Sep
Dec

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 1.2 1.3 1.5 1.2 1.3
Fixed Asset Turnover 1 0.9 1.1 1.6 2
Total Asset Turnover 0.3 0.3 0.4 0.3 0.4
Leverage
Interest Coverage 1.4 1.5 2.6 2.2 2.5
Debt Ratio 2.1 1.4 2.1 1.3 1.8
Debt – Equity Ratio 1.2 1.1 1 1 1.3
Equity multiplier 0.7 0.8 0.8 0.5 0.5